Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Mayo Clinic Cancer Center Support Grant Renewed By NCI, Comprehensive Status Extended
The Mayo Clinic Cancer Center (MCCC) received an additional five years of National Cancer Institute (NCI) funding and re-designation as a comprehensive cancer center, according to Robert Diasio, M.D., the center"s director. Mayo Clinic has the only NCI-designated comprehensive cancer center conducting research at three distinct locations across the United States.

New Disability Learning Activities For GPs
Treating someone with an intellectual disability can be challenging for general
News of the day
Poll: Most Want Health Reform But Fear Its Side Effects
"A majority of Americans see government action as critical to controlling runaway health-care costs, but there is broad public anxiety about the potential impact of reform legislation and conflicting views about the types of fixes being proposed on Capitol Hill, according to a new Washington Post-ABC News poll," The Washington Post reports. "Most respondents are "very concerned" that health-care reform would lead to higher costs, lower quality, fewer choices, a bigger deficit, diminished insurance coverage and more government bureaucracy. About six in 10 are at least somewhat worried about all of these factors, underscoring the challenges for lawmakers as they attempt to restructure the nation"s $2.3 trillion health-care system." Many respondents are "nervous about future changes" because of a "fear they may lose what they currently have. "More than eight in 10 said they are satisfied with the quality of care they now receive and relatively content with their own current expenses." In his news conference Tuesday, President Barack Obama "sought to leverage that apprehension" by noting that "premiums have been doubling every nine years, going up three times faster than wages."
Sexual Health

As The Market Potential Grows, Developers Press For Keys To Delivering Systemic Drugs Via Inhalation

At a time when the drug industry is striving for patient-friendly delivery methods for new and existing drugs, the growing availability of innovative inhaler device designs is driving interest in pulmonary drug delivery technology and devices as an alternative to oral and parenteral routes of administration. While well-established for treating upper respiratory diseases such as asthma and COPD, companies competing in the inhaled drug delivery sector - major players such as GlaxoSmithKline, AstraZeneca and Boehringer Ingelheim as well as pure-play start-ups - continue to view delivery of systemic drugs via inhalation as a major opportunity. The primary reason for the attraction of systemic pulmonary drug delivery lies in converging and related trends in population demographics and disease incidence. As the median age of the global population continues to increase, conditions and diseases such as menopause, osteoporosis, diabetes, and heart disease, which require long-term therapy, are expected to become significantly more prevalent. This is driving a growing emphasis on drug self-administration for chronic conditions and greater interest in noninvasive drug delivery technology. "The historical landscape for inhaled delivery of systemic drugs is marked by disappointment," explains Paul Brooks, Greystone Associates Senior Analyst. "But advances in drug formulation and inhalation device design are moving this technology approach closer to commercialization." Several of these development-stage drug products have the potential to make a significant impact in the therapeutic markets they target, improving patient compliance and effectively changing the way important illnesses and conditions are treated. Developments in this sector are the subject of a comprehensive analysis by Greystone Associates, and are contained in a just-released report that analyzes existing and emerging systemic inhalation products, market participants, and key demand and technology factors influencing the commercial market and shaping growth in this sector. More information is available here. Greystone Associates


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009